377 GENES FOUNDi

Show / hide columns

XML | RDF | TSV | Page of 8 | next »

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

 

 

Subcellular location

x

Prognostic p-value

x

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EHBP1EH domain binding protein 1Disease related genes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Plasma membrane
Cytosol
Urothelial cancer: 1.95e-8
Lung cancer: 9.03e-4
Expressed in all
EMP1Epithelial membrane protein 1Predicted intracellular proteins
Predicted membrane proteins
NucleoplasmOvarian cancer: 2.26e-8
Urothelial cancer: 9.69e-8
Pancreatic cancer: 7.46e-4
Expressed in all
HSPB6Heat shock protein, alpha-crystallin-related, B6Predicted intracellular proteins
Urothelial cancer: 1.43e-6
Renal cancer: 1.93e-5
Tissue enhanced
TM4SF1Transmembrane 4 L six family member 1Predicted membrane proteins
Urothelial cancer: 3.43e-6
Renal cancer: 2.24e-4
Pancreatic cancer: 4.01e-4
Expressed in all
AHNAKAHNAK nucleoproteinPlasma proteins
Predicted intracellular proteins
Plasma membrane
Cytosol
Urothelial cancer: 3.47e-6
Pancreatic cancer: 2.42e-4
Expressed in all
KLK5Kallikrein-related peptidase 5Cancer-related genes
Enzymes
Predicted secreted proteins
Urothelial cancer: 3.85e-6
Endometrial cancer: 2.33e-4
Lung cancer: 9.79e-4
Tissue enriched
MYO1DMyosin IDPlasma proteins
Predicted intracellular proteins
CytosolUrothelial cancer: 4.53e-6
Renal cancer: 5.01e-6
Mixed
PLD1Phospholipase D1, phosphatidylcholine-specificEnzymes
Plasma proteins
Predicted intracellular proteins
RAS pathway related proteins
Plasma membraneUrothelial cancer: 4.76e-6
Tissue enhanced
SHTN1Shootin 1Cancer-related genes
Predicted intracellular proteins
Nucleus
Plasma membrane
Cytosol
Urothelial cancer: 5.08e-6
Prostate cancer: 5.07e-4
Tissue enhanced
HTRA1HtrA serine peptidase 1Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted secreted proteins
Plasma membraneRenal cancer: 7.90e-7
Urothelial cancer: 5.62e-6
Glioma: 8.66e-4
Mixed
DTD2D-tyrosyl-tRNA deacylase 2 (putative)Predicted intracellular proteins
VesiclesUrothelial cancer: 5.74e-6
Head and neck cancer: 9.33e-4
Mixed
ANXA1Annexin A1Cancer-related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Transporters
Nucleoplasm
Plasma membrane
Cytosol
Urothelial cancer: 6.19e-6
Thyroid cancer: 4.57e-5
Endometrial cancer: 5.71e-5
Tissue enriched
C8orf88Chromosome 8 open reading frame 88Predicted intracellular proteins
Urothelial cancer: 6.23e-6
Melanoma: 4.90e-4
Tissue enhanced
BRMS1LBreast cancer metastasis-suppressor 1-likePredicted intracellular proteins
NucleoplasmUrothelial cancer: 6.87e-6
Renal cancer: 6.55e-5
Liver cancer: 1.34e-4
Breast cancer: 5.78e-4
Mixed
SLC1A6Solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6Predicted intracellular proteins
Predicted membrane proteins
Transporters
Intermediate filamentsUrothelial cancer: 6.88e-6
Group enriched
FKBP9FK506 binding protein 9, 63 kDaEnzymes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Golgi apparatus
Vesicles
Mitochondria
Urothelial cancer: 7.02e-6
Head and neck cancer: 2.02e-4
Cervical cancer: 4.22e-4
Glioma: 8.06e-4
Liver cancer: 8.69e-4
Expressed in all
BAIAP2BAI1-associated protein 2Plasma proteins
Predicted intracellular proteins
Plasma membrane
Cytosol
Urothelial cancer: 7.58e-6
Expressed in all
GAS6Growth arrest-specific 6Predicted secreted proteins
Microtubule organizing center
Cytosol
Urothelial cancer: 8.93e-6
Expressed in all
DSC3Desmocollin 3Disease related genes
Plasma proteins
Predicted membrane proteins
Plasma membrane
Cell Junctions
Urothelial cancer: 1.04e-5
Group enriched
BOCBOC cell adhesion associated, oncogene regulatedPredicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Nucleoplasm
Plasma membrane
Urothelial cancer: 1.18e-5
Head and neck cancer: 4.89e-4
Mixed
ECM1Extracellular matrix protein 1Disease related genes
Plasma proteins
Predicted secreted proteins
Nucleoplasm
Cytosol
Renal cancer: 1.51e-9
Urothelial cancer: 1.20e-5
Pancreatic cancer: 3.55e-4
Group enriched
LRP1Low density lipoprotein receptor-related protein 1Candidate cardiovascular disease genes
CD markers
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Nucleoli
Cytosol
Urothelial cancer: 1.29e-5
Renal cancer: 1.52e-5
Expressed in all
SPRR2ASmall proline-rich protein 2APredicted intracellular proteins
Urothelial cancer: 1.37e-5
Tissue enriched
SORBS3Sorbin and SH3 domain containing 3Plasma proteins
Predicted intracellular proteins
Nucleoplasm
Focal adhesion sites
Urothelial cancer: 1.53e-5
Pancreatic cancer: 4.88e-4
Expressed in all
SERPINB2Serpin peptidase inhibitor, clade B (ovalbumin), member 2Cancer-related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Golgi apparatusUrothelial cancer: 1.55e-5
Group enriched
GALK1Galactokinase 1Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Golgi apparatus
Cytosol
Renal cancer: 1.55e-6
Urothelial cancer: 1.62e-5
Expressed in all
MAP1AMicrotubule-associated protein 1AFDA approved drug targets
Plasma proteins
Predicted intracellular proteins
CytosolThyroid cancer: 1.09e-5
Urothelial cancer: 1.66e-5
Renal cancer: 6.59e-5
Tissue enriched
CRYABCrystallin, alpha BCancer-related genes
Disease related genes
Predicted intracellular proteins
Predicted membrane proteins
Plasma membrane
Cytosol
Urothelial cancer: 1.70e-5
Colorectal cancer: 4.90e-5
Tissue enhanced
SCELSciellinPlasma proteins
Predicted intracellular proteins
Nucleoplasm
Plasma membrane
Cytosol
Urothelial cancer: 1.73e-5
Pancreatic cancer: 1.24e-4
Endometrial cancer: 4.07e-4
Renal cancer: 6.87e-4
Tissue enhanced
GSNGelsolinCancer-related genes
Disease related genes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Actin filamentsUrothelial cancer: 1.79e-5
Expressed in all
MXRA7Matrix-remodelling associated 7Predicted intracellular proteins
Predicted secreted proteins
Nucleus
Endoplasmic reticulum
Urothelial cancer: 1.80e-5
Liver cancer: 4.70e-4
Expressed in all
ZHX3Zinc fingers and homeoboxes 3Plasma proteins
Predicted intracellular proteins
Transcription factors
NucleoplasmUrothelial cancer: 1.84e-5
Renal cancer: 2.53e-5
Endometrial cancer: 1.62e-4
Thyroid cancer: 7.52e-4
Expressed in all
FAM83BFamily with sequence similarity 83, member BPredicted intracellular proteins
Urothelial cancer: 1.86e-5
Lung cancer: 1.48e-4
Pancreatic cancer: 7.60e-4
Tissue enhanced
AKR1B15Aldo-keto reductase family 1, member B15Enzymes
Predicted intracellular proteins
Plasma membrane
Cytosol
Liver cancer: 1.80e-5
Urothelial cancer: 1.90e-5
Head and neck cancer: 8.36e-4
Tissue enriched
LRRC59Leucine rich repeat containing 59Predicted intracellular proteins
Predicted membrane proteins
Endoplasmic reticulumRenal cancer: 1.19e-6
Liver cancer: 3.12e-6
Head and neck cancer: 1.00e-5
Urothelial cancer: 1.90e-5
Colorectal cancer: 2.60e-4
Pancreatic cancer: 6.87e-4
Expressed in all
EGFREpidermal growth factor receptorCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Plasma membraneUrothelial cancer: 2.04e-5
Tissue enhanced
HYAL3Hyaluronoglucosaminidase 3Enzymes
Predicted intracellular proteins
Predicted secreted proteins
Urothelial cancer: 2.12e-5
Tissue enhanced
LDLRAD3Low density lipoprotein receptor class A domain containing 3Predicted membrane proteins
Cell JunctionsRenal cancer: 5.05e-8
Lung cancer: 9.34e-6
Urothelial cancer: 2.14e-5
Cervical cancer: 2.24e-4
Mixed
CFL2Cofilin 2 (muscle)Disease related genes
Plasma proteins
Predicted intracellular proteins
Nucleoplasm
Plasma membrane
Cytosol
Urothelial cancer: 2.16e-5
Expressed in all
AHNAK2AHNAK nucleoprotein 2Cancer-related genes
Predicted intracellular proteins
Plasma membrane
Cytosol
Pancreatic cancer: 4.05e-6
Urothelial cancer: 2.23e-5
Lung cancer: 2.79e-5
Tissue enriched
CASQ2Calsequestrin 2 (cardiac muscle)Disease related genes
Predicted secreted proteins
Urothelial cancer: 2.25e-5
Head and neck cancer: 2.30e-4
Tissue enriched
CDK6Cyclin-dependent kinase 6Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Nucleoplasm
Cytosol
Pancreatic cancer: 3.86e-6
Urothelial cancer: 2.33e-5
Mixed
CALM1Calmodulin 1 (phosphorylase kinase, delta)Cancer-related genes
Disease related genes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
RAS pathway related proteins
Transporters
VesiclesUrothelial cancer: 2.38e-5
Pancreatic cancer: 5.62e-4
Renal cancer: 6.49e-4
Expressed in all
GXYLT2Glucoside xylosyltransferase 2Enzymes
Predicted intracellular proteins
Predicted secreted proteins
Nucleoplasm
Cytokinetic bridge
Midbody ring
Renal cancer: 1.46e-7
Urothelial cancer: 2.42e-5
Mixed
HEYLHes-related family bHLH transcription factor with YRPW motif-likePredicted intracellular proteins
Transcription factors
Mitochondria
Cytosol
Renal cancer: 2.26e-6
Urothelial cancer: 2.63e-5
Stomach cancer: 3.57e-4
Mixed
CYTH3Cytohesin 3Predicted intracellular proteins
Nucleoplasm
Cytosol
Urothelial cancer: 2.63e-5
Expressed in all
APLP1Amyloid beta (A4) precursor-like protein 1Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Urothelial cancer: 2.65e-5
Endometrial cancer: 3.87e-4
Tissue enriched
ESYT2Extended synaptotagmin-like protein 2Plasma proteins
Predicted membrane proteins
CytosolUrothelial cancer: 2.81e-5
Pancreatic cancer: 5.73e-4
Expressed in all
GARSGlycyl-tRNA synthetaseDisease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted secreted proteins
CytosolRenal cancer: 1.70e-5
Urothelial cancer: 3.04e-5
Liver cancer: 8.95e-5
Breast cancer: 1.02e-4
Endometrial cancer: 8.48e-4
Expressed in all
CERCAMCerebral endothelial cell adhesion moleculePredicted intracellular proteins
Predicted secreted proteins
Nucleus
Nucleoli
Cell Junctions
Renal cancer: 3.33e-16
Urothelial cancer: 3.30e-5
Ovarian cancer: 5.22e-4
Expressed in all

Page of 8 | next »